Procedural Lapses Land Safetec an FDA Form 483

Drug GMP Report
A A
Safetec of America, a maker of first-aid drugs and disinfectants, failed to thoroughly follow its own testing and investigation procedures whether or not a potentially defective batch had already been distributed, an FDA Form 483 says.

To View This Article:

Login

Subscribe To Drug GMP Report

Buy This Article Now

Add this article to your cart for $135.00